Cladrim belong to Class of drugs - Chlorinated purine nucleoside analogue


The recommended dose and schedule of Cladribine Injection for active Hairy Cell Leukemia is a single course given by continuous infusion for 7 consecutive days at a dose of 0.09 mg/kg/day. It is advised to proceed carefully in patients with known or suspected renal insufficiency or severe bone marrow impairment of any etiology.


Cladribine is indicated for the treatment of Hairy Cell Leukemia

Product Information

Cladrim is available as 10mg Injection.


For the use only of a Registered Medical Practitioner or a Hospital or a Laboratory